Académique Documents
Professionnel Documents
Culture Documents
ARTICLE
*
1
E-mail: stefbar@gmail.com.
See generally Alison Jones and Brenda Sufrin EU Competition Law
(Oxford University Press Oxford 2011), 718, and Guifang Yang and Keith
E Maskus Intellectual Property Rights, Licensing, and Innovation (2003)
2973 World Bank Policy Research Working Paper 1.
Mirza Gogic Intellectual Property Licensing for the Purpose of the
Technology Transfer Block Exemption Regulation (2012) 1 Nordic Journal
of Commercial Law 1, 3:
Most licenses bear royalties, either in a form of a lump sum, or as
running royalties. . . . Even in cases where a license does not bear
# The Author(s) (2014). Published by Oxford University Press. All rights reserved.
The author
Stefano Barazza is a lawyer at Studio Legale Barazza, in
Italy.
This article
The technology transfer realized through the licensing
doi:10.1093/jiplp/jpt235
7
8
9
10
11
187
is the transfer of systematic knowledge for the manufacture of a product, for the application of a process or for
the rendering of a service and does not extend to the
transactions involving the mere sale or mere lease of
goods. Additional provisions clarified that the transfer
usually involves (i) the assignment, sale and licensing of
all forms of industrial property, except for trade marks,
and (ii) the provision of know-how and technical
expertise.8
The Standing Committee on the Law of Patents (SCP)
of the World Intellectual Property Organization, in its
14th session,9 provided an overview of the role of these
agreements,10 clarifying from a general perspective that
they have significant beneficial effects for (1) the companies, as they improve competitiveness, add value in
the commercial chain, promote cooperation and collaboration, contribute to building technical expertise and
know-how; (2) the society at large, by promoting the
dissemination and further creation of knowledge and
technology,11 acting as a catalyst for economic growth,
encouraging the creation of local industries and increasing the competitiveness of the national industry sector
in the global market;12 and (3) consumers, through
indirect effects on the availability of technologically
advanced products at low cost. This beneficial flow of
technology not only allows the licensee to use patented
technology for inclusion in its products and services,
against the payment of a royalty, but also increases its
understanding of the technology, stimulating further
innovation, and promotes joint venture agreements and
collaborative research efforts.13
In this context, the development of rules aimed at
dealing with the licensing of technology pursued two
converging objectives: first, to stimulate the widespread
dissemination of technology and increase the efficiency of
the process14 and, secondly, to reduce the negative impact
12
13
14
ARTICLE
188
ARTICLE
15
16
17
33
189
34
35
36
37
38
39
ARTICLE
190
ARTICLE
40
41
42
43
44
45
46
47
51
52
53
54
by Article 101(1) was expressly provided in AOIPBeyrard 40 (territorial exclusivity, conditional export
prohibitions, non-challenge clauses, obligations to pay
royalties in respect of expired or unused patents, or in
relation to products manufactured using alternative
technologies developed by the licensee or third parties,
and non-competition clauses41). Generally, the Commission noted that patent licensing agreements are not
automatically within Article [101(1)] if the agreements
simply confer rights to exploit patented inventions
against payment of royalties, but may be caught by it if
a grant is accompanied by terms which go beyond the
need to ensure the existence of an industrial property
right, or where the exercise of such right is found to be
the object, means or consequence of a restrictive
agreement.42
The new sensitivity towards the potential anti-competitive effects of exclusive licensing agreements and
other licensing terms primarily stem from the development of the exhaustion of rights doctrine,43 and of the
distinction between existence and exercise of a right.44
The Court of Justice judgment in L C Nungesser KG and
Kurt Eisele v Commission 45 provided the first review of
the restrictive approach taken by the Commission in the
1970s. The case concerned a licensing agreement for
hybrid maize seeds, which conceded exclusive territorial
distribution rights to the licensee. The Commission had
found that exclusivity and territorial provisions fell
within Article 101(1), but the Court of Justice took a
step further.46 Drawing a distinction between open and
closed exclusive licences,47 the Court found that the
former, under which the licensor agreed not to grant
other licenses, nor to compete itself, in the same territory, were not incompatible per se with Article 101(1)
TFEU,48 while the latter, which conferred absolute territorial protection and prohibited parallel imports, went
55
56
57
58
59
60
61
62
63
191
64
65
66
67
ARTICLE
192
ARTICLE
mere payment of royalties in exchange for patent licensing generally restricted the commercial freedom of the
parties, with the exception of those terms specifically
examined by the Commission in previous cases.
In the Evaluation Report on the Transfer of Technology Block Exemption Regulation 240/9668 published in
2001, the Commission acknowledged the criticism,
highlighting that Regulation 240/96:
68
69
70
71
72
73
74
75
76
77
78
79
ARTICLE
193
The new economic-based approach endorsed by Regulation 772/2004 relies on an evaluation of the effects of restrictive licensing terms on the overall pro-competitive
impact of technology transfer agreements: these effects
depend, according to the Commission, on the market
power of the parties, and on the extent to which they
face competition from undertakings owning substitute
technologies or producing substitute products.81 Essentially, the Regulation submits the block exemption to
two cumulative conditions, concerning the respect of
specific market-share thresholds, and the absence of
hard-core restrictions (severely anti-competitive
restraints82). Where the conditions are fulfilled, there is
a presumption that the agreements generally lead to an
improvement in production or distribution and allow
consumers a fair share of the resulting benefits.83
The block exemption applies only to bilateral84 technology transfer85 agreements permitting the production
of contract products which, according to Article 1.1(b)
of Regulation 772/2004, comprise (i) pure agreements
for the licensing of patents,86 know-how, or software
copyright and (ii) mixed agreements, including those
80
92
81
82
83
84
85
86
87
88
89
90
91
93
94
95
related to the sale and purchase of products or to the licensing of other intellectual property rights,87 provided
that such provisions are not the primary object of the
agreement and are directly related to the production of
the contract products.88 Licences containing provisions
imposing specific obligations on the licensee as to the way
in which he must sell the products incorporating the
licensed technology benefit from the block exemption,
provided that they also satisfy the conditions set by Regulation 2790/1999 on vertical agreements.89 Agreements for
the purpose of subcontracting research and development,90 or to set up technology pools, as well as supply
and distribution agreements, are instead expressly
excluded from the field of application of the exemption.91
Article 2 enunciates the block exemption, which
applies only if the following conditions are collectively
satisfied:
194
ARTICLE
96
97
98
99
100
101
102
103
104
105
106
See, generally, Guidelines, above, n 23, para 68. According to ibid, para 32,
[i]f the parties own technologies that are in a one-way or two-way
blocking position, they are considered to be non-competitors on the
technology market. A special case is contemplated by ibid, para 33: an
agreement between competitors may change into a relationship between
non-competitors, if the licensees technology is obsolete or uncompetitive
on the relevant markets, or later becomes so.
If, during the duration of an exempted agreement, the market share of the
parties exceeds the threshold set by Article 3 of Regulation 772/2004,
above, n 21, the block exemption continues to apply for an interim period
of two years, following the year in which the threshold is exceeded (ibid,
Article 8(2)).
Guidelines, above, n 23, para 65.
See also Article 4.3, which states that, if the undertakings were noncompetitors at the time of conclusion of the agreements and later become
competitors, the list of hardcore restrictions for non-competing parties
continues to apply, unless the agreement is amended.
Further, these restrictions are also unlikely to satisfy Article 101(3) TFEU,
when individually assessed (see Guidelines, above, n 23, paras 18 and 74
76).
For indirect price fixing, see ibid, para 78.
On cross-licensing agreements with running royalties, ibid, para 79.
Which can take the form of minimum or maximum caps, fixed royalties
or recommended prices (ibid).
Liable to reduce output in the market, even if they merely restrict the
incentive of the parties to expand output (ibid, para 82).
According to ibid, para 84, these restrictions are caught by Article 4
irrespective of whether the licensee remains free to use his own
technology, as the licensee would incur in significant costs to maintain
separate lines of production, and thus have little incentive to produce
using its own technology.
Exceptions include: (i) field of use and product market restrictions; (ii)
field of use, product market, and territorial restrictions, imposed on the
107
108
109
110
111
112
113
114
115
116
117
195
ARTICLE
196
ARTICLE
obligations which are generally not restrictive of competition: confidentiality obligations, obligations on
licensees not to sub-license; obligations not to use the
licensed technology after the expiry of the agreement,
provided that the licensed technology remains valid
and in force; obligations to assist the licensor in enforcing the licensed intellectual property rights; obligations to pay minimum royalties or to produce a
minimum quantity of products incorporating the
licensed technology; and obligations to use the licensors trade mark or indicate the name of the licensor
on the product;129
royalty obligations,130 which are assessed taking into
account the competitive relationship between the
parties, with particular attention to sham licences,
disproportionate royalty rates, foreclosure effects
arising from the determination of royalties in relation
124
125
126
127
128
129
130
131
132
133
134
135
136
market and the licensor lacks the production and distribution assets to
effectively bring to market products incorporating the licensed
technology.
Guidelines, above, n 23, para 167.
Ibid, paras 168 174.
Ibid, para 170. Similar treatment in reserved to non-reciprocal agreements
with restrictions on active sales into the territory or to the customer
group allocated to another licensee, who was not a competitor of the
licensor at the time when he concluded the licence agreement.
Restrictions to passive sales are hard-core restrictions under Art 4.1(c)
TTBER.
Guidelines, above, n 23, paras 175 178.
197
output of the licensees production;137 the combination of output restrictions and exclusive licensing
increases the restrictive effects;
non-compete obligations138 may lead to foreclosure
of third-party technologies and facilitate collusion
between licensors; their restrictive potential is sensitive, inter alia, to the market power of the parties, the
presence of entry barriers, and the cumulative effect
of agreements concluded by several licensors; among
their pro-competitive effects, the Guidelines recall (i)
the prevention of misappropriation of the licensed
technology, in particular know-how, (ii) the provision
of an incentive to the licensee to invest in the licensed
technology and exploit it effectively and (iii) the provision of an incentive to the licensor, when it has to
make significant client-specific investments.
Other provisions concern field of use restrictions,139
captive use restrictions140 and tying and bundling.141
ARTICLE
198
ARTICLE
ARTICLE
In December 2011, the Commission launched a preliminary public consultation, seeking the stakeholders
views166 on their experience with the block exemption,
and suggestions for suitable improvements to the regime
introduced by Regulation 772/2004, in light of its
scheduled expiry on 30 April 2014. In February 2013, a
draft revised Technology Transfer Block Exemption
Regulation was published.167 The proposal includes the
following main changes:168
the exclusion, from the field of application of the
block exemption, of research and development agreements falling within the scope of Regulation 1217/
2010169 (Art 9), of specialization agreements covered
by Regulation 1218/2010170 (para 58 of the revised
Guidelines) and of agreements the purpose of which
is the mere reproduction and distribution of software
copyright protected products (Recital 7);171
a set of new definitions for the notions of technology
(which comprises, according to Art. 1.1(b), knowhow, patents, utility models, design rights, topographies of semiconductor products, supplementary
protection certificates, plant breeders certificates and
software copyright), and technology transfer agreement (which covers licensing agreements related to
199
200
ARTICLE
Draft revised
TTBER
Mixed agreements
(containing
provisions related to
the purchase of
products by the
licensee or to the
licensing of other
IPRs not included in
the TTBER
definition)
Agreements between
non-competitors,
when the licensee
owns a substitute
technology, which it
uses only for inhouse production
Two-year restriction
of passive sales by a
non-competitor
licensee into an
exclusive territory or
to an exclusive
customer group
allocated to another
licensee
Allowed
If concerning
severable
improvements, it
constitutes an
excluded restriction.
Constitutes an
excluded restriction,
both in relation to
severable and
non-severable
improvements
If concerning
non-severable
improvements, it is
allowed.
Non-challenge
clause
Constitutes an
excluded restriction, if
imposed to the
licensee
Constitutes an
excluded restriction,
if imposed to either
party
Termination clause
Allowed, in relation to
challenges brought by
the licensee against
the licensed IPRs
Always constitutes
an excluded
restriction, even if
imposed on the
licensor or
concerning nonlicensed IPRs that
the other party
holds in the EU
Regulation 772/2004
Exclusive grant-back
and assignment of
improvements made
by the licensee
Departing from the previous perspective, para 231 clarifies that neither pooling agreements, nor licensing agreements between the pool and third parties, as multiparty
agreements, are covered by the block exemption. Among
the provisions concerning the latter agreements, para
250 provides a modified list of principles applicable: new
principles include (i) the stronger the market position of
the pool, the more likely that agreeing not to license to
all potential licensees or to license on discriminatory
183 Guidelines on the applicability of Article 101 of the Treaty on the
Functioning of the European Union to horizontal co-operation
agreements [2011] OJ C 11/1 (Horizontal Guidelines).
184 The same principle is enshrined in the current Guidelines, above, n 23,
para 231.
185 Revised Guidelines, above, n 171, para 229.
186 Ibid, para 256 introduces a new provision, which deals with the inclusion,
in the pool, of patent applications, inviting pool members to use the
patent application procedures that allow for faster granting.
187 Current Guidelines, above, n 23, para 226.
188 See Inquiry into competition in the pharmaceuticals sector IP/09/1098
[2009], and the Final Report of 8 July 2009.
189 See Cases T-321/05 [2010] AstraZeneca v Commission ECR II-02805, and
C-457/10 P AstraZeneca v Commission, 6 December 2012.
190 European Commission, Assessment of potential anticompetitive conduct
in the field of intellectual property rights and assessment of the interplay
201
terms will infringe Article 101 TFEU, and (ii) the technology transfer agreements should not contain any of
the hard-core restrictions listed in Article 4 of the block
exemption. As pertaining to non-challenge obligations,
including termination clauses, the proposal clarifies that
they are likely to fall under Article 101(1) TFEU, modifying the previous approach that allowed termination
clauses within the boundaries of the relationship between
the challenged licensor and the licensee.185 Finally,186 the
fair and non-discriminatory licensing commitment prescribed by the current Guidelines in relation to pools
enjoying a dominant position on the market,187 is now
replaced by a FRAND commitment, as defined by para
287 of the Horizontal Guidelines.
ARTICLE
202
ARTICLE
In this context, the introduction of a specific provision to directly address pay-for-restriction and payfor-delay clauses in settlement agreements is particularly
relevant. Paragraph 223 of the revised Guidelines now
clarifies that:
193 The Commission noted that direct payments aimed at restricting access to
the market for generic manufacturers, have attracted antitrust scrutiny in
the USA.
194 MEMO/09/321 [2009].
195 IP/13/563 [2013]. Other investigations are pending (IP/12/835 and IP/13/
81).
196 The Statement of Objections had been sent in July 2012. See IP/12/834
[2012].
197 Federal Trade Commission v Actavis Inc and others, Docket No. 12-416
(2013).
198 Standard Oil Co of New Jersey v United States, 221 US 1 (1911).
199 Similarly, the last sentence the revised Guidelines, above, n 171, para 227
targets reverse-payment settlements in which the licensor induces,
financially or otherwise, the licensee to agree not to challenge the validity
of the technology.
200 C-457/10 P AstraZeneca, above, n 189. The judgments reviewed a
Commissions decision, which found that AstraZeneca had committed
two abuses of a dominant position. In particular, the first abuse consisted,
according to the Commission, in misleading representations to patent
latter.193 The Commission found that [i]n approximately 50% [of the settlements concluded between originators and generic companies] generic entry was restricted
and in approximately half of these there was a value
transfer from the originator to the generic company,194
and that [m]ore than 10% of the settlements were
so-called reverse payment settlements which provided
for direct payments, amounting in total to more than
EUR 200 million.
In the Final Report, the Commission noted that
[s]ettlement agreements that limit generic entry and
include a value transfer from an originator company to
one or more generic companies are an example of . . .
potentially anticompetitive agreements, in particular
where the motive of the agreement is the sharing of
profits via payments from originator to generic companies to the detriment of patients and public health
budgets. On 19 June 2013,195 following an investigation
which lasted almost a year,196 the Commission imposed
fines of EUR 93.8 million and 52.2 million respectively
on the pharmaceutical giant Lundbeck and several
generic manufacturers, for concluding pay-for-delay
agreements, contrary to Article 101 TFEU, in relation to
the entry into the market of generic versions of Lundbecks citalopram, a blockbuster anti-depressant.
The sensitive approach to the issue exhibited by the
Commission, signals a general awareness of the anticompetitive potential of similar agreements. In this
perspective, on 17 June 2013, the US Supreme Court
disclosed its position on reverse-payment settlements in
Federal Trade Commission v Actavis Inc:197 the court
refused the quick look approach advocated by the FTC
and held that the assessment of these settlements requires
the application of the rule of reason,198 finding that a
reverse payment, where large and unjustified, can bring
with it the risk of significant anticompetitive effects.
203
ARTICLE
204
ARTICLE
210 For a detailed list of the studys conclusions, see ibid, 32.
211 Revised Guidelines, above, n 171, para 250(b).
212 Which constitutes, per se, one of the reasons that allow pools to include
complementary but non-essential technologies, ex para 247(a). This
provision clarifies that the assessment of these pools should take into
account whether there are any pro-competitive reasons for including the
non-essential technologies in the pool, for example due to the costs of
assessing whether all the technologies are essential in view of the high
number of technologies.
213 See eg IGR Stereo-Television/Salora in the Commissions XI Competition
Policy Report (1982), 63.
214 Horizontal Guidelines, above, n 183.
215 As exemplified by the Commissions investigations on Samsungs and
Motorolas use of injunctions for the enforcement of standard-essential
patents, IP/12/1448 [2012] and IP/13/406 [2013]. See also Case C-170/13
Huawei Technologies, pending before the Court of Justice, which concerns
the availability of injunctions against willing potential licensees of the
essential technologies.
216 See, generally, Mark A Lemley Intellectual Property Rights and StandardSetting Organizations (2002) 90(6) California Law Review 1889.
The revised rules on technology pools constitute a refinement of the antitrust policy which case law has been
carving since the 1980s.213 As of late, the Commission
has focused on the definition and consequences of
FRAND licensing commitments, which the revised
Guidelines apply to patent pools, following the approach
of the Horizontal Guidelines.214 In particular, the Commissions concerns appear to concentrate on the use of
injunctive relief against willing licensees,215 which is frequently seen as a form of anti-competitive leverage on
the increased market power conferred by the dominant
position of the essential patent holders.216 In the context
of patent pools, the rules on governance and participation refined by the proposed reform address similar concerns, and are likely to discourage and prevent abusive
conducts by pool members, strengthening the Commissions favourable approach towards pools which adopt
the institutional framework set out in para 244. The
revised Guidelines, however, do not contemplate a methodology for the calculation of FRAND rates, nor impose
a royalty cap,217 to the effect that the royalty calculation
remains subject to the general principles contained in ss
paras 289 and 290 of the Horizontal Guidelines.218
205
Such clauses may respectively (i) discourage the licensee225 from challenging the validity of the licensed technology, and perpetuate the exclusionary effects of an
invalid monopoly, and (ii) discourage the licensee from
actively developing improvements of the licensed technology, reducing intra-technology competition and the
overall development of the relevant technology market,
foreclosing third parties interested in licensing the
improvements, and conferring increased market and
bargaining power on the licensor. These concerns
provide sufficient justification for the submission of
termination and grant-back provisions to an individual
assessment of their compatibility with Article 101(1)
TFEU.226
The evaluation of the proposed changes concerning
restrictions to passive sales and the application of the
20 per cent combined market share to non-competitors,
when the licensee owns a substitute technology used
only for in-house production, raises significant issues.
The first change, under which the previously exempted
two-year restrictions of passive sales by a non-competitor licensee into an exclusive territory or to an exclusive
customer group allocated to another licensee become
hard-core restrictions, harmonizes the TTBER with
Regulation 330/2010,227 concerning vertical supply and
distribution agreements. However, several stakeholders228 questioned the rationale underlying this
harmonization, highlighting the differences between the
agreements disciplined by the two regulations. Further,
it was observed that, although the restriction can be
individually exempted if objectively necessary for the
licensee to penetrate a new market, such burden of proof
would undermine legal certainty,229 and could discourage competition by smaller undertakings attempting to
enter new markets, or markets characterized by dominant players. The second change incurs the risk of (i)
muddling the distinction between competitors and
226 See also s 5.6 of the Antitrust Guidelines, according to which, in the USA,
the evaluation of grant-back provisions requires the use of the rule of
reason, and takes into account their likely effects in light of the overall
structure of the licensing arrangement and conditions in the relevant
markets.
227 See above, n 168.
228 See e.g. City of London Law Society. Bird & Bird submitted that [t]he
Commission appears to be concerned that in certain instances, such
investments by licensees may not be made. Any such reaction is in our
view disproportionate, given that as a general rule licensees under
agreements covered by the draft Regulation are producing contract
products for which appropriate investments are expected and needed.
This is in contrast to the position under a vertical agreement where
transaction specific investments are much less likely on the part of the
buyer/distributor.
229 City of London Law Society.
ARTICLE
206
ARTICLE
Further, the national courts now entrusted with applying the block exemption to technology licensing agreements may encounter practical problems in defining the
appropriate markets for technology and products based
thereon, and in determining the objective necessity of
licence terms.234
ARTICLE
207